High quality - fair price, a clinical research contradiction?

Not if you have already maximised the cost effectiveness of your clinical research, maintained good quality and shortened your time to market. Or, if  you don't mind spending $1 billion plus on developing and marketing your new drug and are happy with only having 5 years patent life left, who cares!

For most of us, however, especially in today's economic climate, it is paramount that cost effectiveness be maximised and time to market shortened, without any encroachment into quality standards and despite increased workload due to increasing complexity of clinical research methodology, regulatory procedures and globalisation. If you are interested in discussing how to use your clinical research resources efficiently and to increase the efficiency of your study procedures, HCR is hosting an industry event on:

23. October 2009

to discuss " Cost Effectiveness in Clinical Trials".  Key members of the  pharmaceutical/biotechnological/medical device and food industries have been invited to attend this event, at our headquarters in Munich, which will start at 10-00 hr with a presentation followed by a Round Table with invited participants and chaired by Dr. Harrison. After lunch, you will be given a comprehensive tour of HCR facilities and the opportunity for further discussions with other guests.

If you want any more information about this important  event or want to register your participation, please contact Barbara Schnurr on ++49 (0)89 126680- 2211 or e-mail her using the contact button below.

ContactBarbara Schnurr,
Harrison Clinical Research